4//SEC Filing
Catinazzo Thomas 4
Accession 0000950170-24-141597
CIK 0001812364other
Filed
Dec 30, 7:00 PM ET
Accepted
Dec 31, 4:05 PM ET
Size
7.1 KB
Accession
0000950170-24-141597
Insider Transaction Report
Form 4
Catinazzo Thomas
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-12-27$4.38/sh−299$1,310→ 303,792 total - Sale
Common Stock
2024-12-27$4.42/sh−4,566$20,182→ 299,226 total
Footnotes (4)
- [F1]Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 992 shares of restricted stock units ("RSUs") on December 26, 2024. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
- [F2]Includes 291,498 shares underlying RSUs.
- [F3]The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024.
- [F4]This transaction was executed in multiple trades at prices ranging from $4.37 to $4.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Documents
Issuer
Relay Therapeutics, Inc.
CIK 0001812364
Entity typeother
Related Parties
1- filerCIK 0001818261
Filing Metadata
- Form type
- 4
- Filed
- Dec 30, 7:00 PM ET
- Accepted
- Dec 31, 4:05 PM ET
- Size
- 7.1 KB